2026-04-13T07:08:21Zhttps://recercat.cat/oai/request

oai:recercat.cat:2072/4646102026-03-13T10:34:41Zcom_2072_98col_2072_378192

00925njm 22002777a 4500 dc Verploegen, Maartje F A. author Vargas-Poussou, Rosa author Walsh, Stephen B. author Alpay, Harika author Amouzegar, Atefeh author Ariceta Iraola, Gema author Atmis, Bahriye author Bacchetta, Justine author Bárány, Peter author Baron, Stéphanie author Bayrakci, Umut Selda author Belge, Hendrica author Besouw, Martine author Blanchard, Anne author Bökenkamp, Arend author Boyer, Olivia author Burgmaier, Kathrin author Calò, Lorenzo A. author Decramer, Stéphane author Devuyst, Olivier author van Dyck, Maria author Ferraro, Pietro Manuel author Fila, Marc author Francisco, Telma author Ghiggeri, Gian Marco author Gondra, Leire author Guarino, Stefano author Hooman, Nakysa author Hoorn, Ewout J. author Houillier, Pascal author Kamperis, Konstantinos author Kari, Jameela A. author Konrad, Martin author Levtchenko, Elena author Lucchetti, Laura author Lugani, Francesca author Marzuillo, Pierluigi author Mohidin, Barian author Neuhaus, Thomas J. author Osman, Abdaldafae author Papizh, Svetlana author Perelló, Manel author Rookmaaker, Maarten B. author Conti, Valerie Said author Santos, Fernando author Sawaf, Ghalia author Serdaroglu, Erkin author Szczepanska, Maria author Taroni, Francesca author Topaloglu, Rezan author Trepiccione, Francesco author Vidal, Enrico author Wan, Elizabeth R. author Weber, Lutz author Yildirim, Zeynep Yuruk author Yüksel, Selçuk author Zlatanova, Galia author Bockenhauer, Detlef author Emma, Francesco author Nijenhuis, T. author Universitat Autònoma de Barcelona author 2022 Small cohort studies have reported high parathyroid hormone (PTH) levels in patients with Bartter syndrome and lower serum phosphate levels have anecdotally been reported in patients with Gitelman syndrome. In this cross-sectional study, we assessed PTH and phosphate homeostasis in a large cohort of patients with salt-losing tubulopathies. Clinical and laboratory data of 589 patients with Bartter and Gitelman syndrome were provided by members of the European Rare Kidney Diseases Reference Network (ERKNet) and the European Society for Paediatric Nephrology (ESPN). A total of 285 patients with Bartter syndrome and 304 patients with Gitelman syndrome were included for analysis. Patients with Bartter syndrome type I and II had the highest median PTH level (7.5 pmol/L) and 56% had hyperparathyroidism (PTH. Bartter syndrome Gitelman syndrome Parathyroid hormone Phosphate Salt losing tubulopathies Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome : an international cross-sectional study